Effect of tranexamic acid on melasma: a clinical trial with histological evaluation
Top Cited Papers
- 13 February 2012
- journal article
- clinical trial
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 27 (8), 1035-1039
- https://doi.org/10.1111/j.1468-3083.2012.04464.x
Abstract
Background Melasma is associated with epidermal hyperpigmentation, weak basement membrane, vascular proliferation and increased numbers of mast cell. Tranexamic acid (TXA), a plasmin inhibitor, is reported to improve melasma when injected locally. However, the effects of oral and topical TXA on melasma have not been well studied and the underlying mechanism remains unclear. Objectives To elucidate the effects of oral and topical TXA on melasma. Methods A clinical study was conducted with 25 women for 8 weeks from March to July 2010. Volunteers were instructed to take two TXA tablets three times a day and apply a TXA topical agent twice a day for 8 weeks. Skin pigmentation and erythema was measured using a Mexameter® during each visit and skin biopsies were collected from eight subjects before and 8 weeks after treatment. Fontana‐Masson, anti‐CD31, antitryptase and antitype IV collagen staining was performed. Results Twenty‐two subjects completed the study and no serious adverse events occurred during the study period. The mean lesional melanin index (MI) scores decreased significantly. Interestingly, the MI scores for the perilesional skin increased. The erythema index scores of lesional and perilesional skin also showed a similar pattern. Histological analysis showed significant reduction of epidermal pigmentation, vessel numbers and mast cell counts. Type IV collagen staining was not observed in all specimens. Conclusion TXA decreased epidermal pigmentation associated with melasma and also reversed melasma‐related dermal changes, such as vessel number and increased numbers of mast cells.Keywords
This publication has 19 references indexed in Scilit:
- Histochemical and Immunohistochemical Study in Melasma: Evidence of Damage in the Basal MembraneThe American Journal of Dermatopathology, 2011
- A randomized, double‐blind, placebo‐controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino womenInternational Journal of Dermatology, 2009
- Solar elastosis and presence of mast cells as key features in the pathogenesis of melasmaClinical and Experimental Dermatology, 2008
- The vascular characteristics of melasmaJournal of Dermatological Science, 2007
- Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian Patients: A Preliminary Clinical TrialDermatologic Surgery, 2006
- The dermal stem cell factor and c-kit are overexpressed in melasmaBritish Journal of Dermatology, 2006
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transferBritish Journal of Dermatology, 2002
- Melasma: histopathological characteristics in 56 Korean patientsBritish Journal of Dermatology, 2002
- Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentationJournal of Photochemistry and Photobiology B: Biology, 1998
- Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cellsAmerican Journal of Physiology-Cell Physiology, 1993